Endocrine University® Nov 2019

Endocrine University®: Disease Management & Technology Skills for Endocrinology Fellows-in-Training

 

The field of clinical endocrinology is extremely diverse considering the multiple disease states endocrinologists must diagnose and manage on a daily basis (e.g., diabetes, thyroid, osteoporosis, lipids, reproduction, pituitary, obesity, hypertension, etc.).  Endocrinology fellows -in-training and their endocrine training program directors have recognized a growing need to significantly enhance the endocrine curriculum, particularly in those areas where new technology has become essential to the practice of endocrinology. Regrettably, the majority of the endocrine training programs lack the resources necessary to provide adequate education in these areas. This deficiency is apparent by virtue of the overwhelming response by AACE members who have registered for existing accreditation/certification courses provided by AACE and ACE since 1995, and by our endocrinology fellow members who have indicated a need for a comprehensive course that fills this educational void.

Target Audience

This program is specifically designed for Second Year Endocrine Fellows-in-Training.

Learning Objectives

  • At the end of this activity, participants will be able to:

  • Effectively utilize new diagnostic technology that has become essential to the practice of endocrinology.

  • Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of endocrine-related disorders

  • Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of endocrine-related practice.

Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Hypertension
Hypoglycemia
Lipids
Nutrition
Obesity
Parathyroid & Bone
Thyroid
UGFNA
Course summary
Available credit: 
  • 22.00 AMA
  • 22.00 Attendance
Course opens: 
11/05/2019
Course expires: 
12/31/2019

Endocrine University®

Disease Management & Technology Skills for Endocrinology Fellows in Training

Kahler Grand Hotel - Rochester, MN

November 7- 10, 2019

COURSE ROOM LOCATION

Marriott Ballroom, 2nd Floor = (MB)Heritage Ballroom Foyer, Kahler Hotel, Subway Level = (HBF)
Heritage Ballroom, Kahler Hotel, Subway Level = (HB) 
  

REGISTRATION - THURSDAY, NOVEMBER 7, 2019

5:00-6:30 pm    Registration

6:30- 7:30 pm  Product Theater and Dinner Presented by Abbott (HB)

PROGRAM - FRIDAY, NOVEMBER 8, 2019

Schedule and Sessions
Time
Event
Supporting Files
6:30-7:30 am  

Breakfast and Exhibits (HBF)-

 

Rethinking Lipid Management to Reduce CVD: Statin Therapy & Beyond (HB)

Moderator:  Vinaya Simha, MD, MBBS

 
7:30-8:00 am 

Lipid Physiology and Pathogenesis of Monogenic Lipid Disorders

Vinaya Simha, MD, MBBS

                                    Objectives:

  1. Appreciate the role of lipids in multiple physiological processes.
  2. Explain the basic principles of lipoprotein structure and function.
  3. Discuss the molecular basis of genetic disorders of lipid metabolism and transport.
VIEW PRESENTATION
8:00-8:45 am

Landmark Lipid Trials and Current Lipid Treatment Guidelines -

Stephen Kopecky, MD

                                    Objectives:

  1. Briefly review major primary and secondary prevention trials of statin therapy.
  2. Review the evidence from non-statin trials to understand the role of combination lipid lowering therapy.
  3. Discuss the basis and limitations of different lipid treatment guidelines.
VIEW PRESENTATION
8:45-9:30 am 

Residual Risk and Novel Therapies - 

Vinaya Simha, MD, MBBS

                                    Objectives:

  1. Appreciate the magnitude of residual cardiovascular risk after statin therapy.
  2. Discuss the basis for novel and emerging lipid lowering therapies.
  3. Review evidence for efficacy of novel therapies to understand their role in clinical practice.
VIEW PRESENTATION
9:30-9:40 am

Question and Answer Session -

Vinaya Simha, MD, MBBS and Stephen Kopecky, MD

 
9:40-10:00 am

Break and Exhibits (HBF)- 

Obesity Medicine – An Interactive Session Utilizing the Audience Response System (HB)

Moderator: Daniel Hurley, MD, FACE

 
10:00-10:25 am

Obesity Pathophysiology and AACE Obesity CPGs

Daniel Hurley, MD, FACE

                                    Objectives:

  1. Discuss medical models of obesity management and rationale for a complications centric approach.
  2. Review the evidence demonstrating weight loss as an effective therapeutic tool to treat obesity-related complications.
VIEW PRESENTATION
10:25-10:50 am

Lifestyle Management with Diet, Activity/Exercise, and Behavior Support

Meera Shah, MB, ChB, MRCP

                                    Objectives:

  1. Review the principles of effective lifestyle intervention as a key role in obesity medicine.
  2. Discuss the impact of weight loss therapy regarding type-2 diabetes prevention.
VIEW PRESENTATION
10:50-11:15 am

Medical Management of Obesity -

Meera Shah, MB, ChB, MRCP

                                    Objectives:

  1. Review the efficacy, safety, and role of medications in obesity management.
  2. Explain the impact of weight loss medical therapy in preventing type-2 diabetes.
VIEW PRESENTATION
11:15-11:40 am

Surgical Management of Obesity - 

Daniel Hurley, MD, FACE

                                    Objectives:

  1. Review the efficacy, safety, and role of bariatric surgery in obesity management
  2. Discuss the impact of bariatric weight loss therapy in the treatment of type-2 diabetes
VIEW PRESENTATION

11:40-12:00 pm

Question and Answer Session

Meera Shah, MB, ChB, MRCP and Daniel Hurley, MD, FACE

 
12:00-1:30 pm  

Lunch/Welcoming Remarks (HB) -

Daniel Hurley, MD, FACE, Immediate Past-President, AACE                                   

                                    Robert Wermers, Chair, Mayo Division of Endocrinology and Metabolism

                                    Thom W. Rooke, MD, FSVM, “Quest for Cortisone”

VIEW PRESENTATION
1:30-2:45 pm

Cushing Syndrome (HB) -

Susan L. Samson, MD, PhD, FRCPC, FACE

Objectives:

  1. Review the diagnostic approach to the patient with possible Cushing syndrome
  2. Describe the levels of diagnostic testing in evaluating a patient with Cushing syndrome including inferior petrosal sinus sampling
  3. Discuss the treatment options for Cushing’s syndrome and disease
VIEW PRESENTATION
2:45-4:00 pm

Adrenal Insufficiency -

Irina Bancos, MD

Objectives:

  1. Describe the etiology and presentation of adrenal insufficiency.
  2. Review the diagnostic approach to the patient with possible adrenal insufficiency.
  3. Discuss steroid replacement strategies.
VIEW PRESENTATION
4:00 – 4:30 pm

Break and Exhibits (HBF)

 
4:30-5:15 pm 

Growth Hormone Replacement: Not Just for Kids?

Dana Erickson, MD, FACE

                                    Objectives:

  1. Describe the causes, symptoms and clinical consequences of growth hormone deficiency in adult patients.
  2. Identify the appropriate dynamic testing for the diagnosis of growth hormone deficiency in adults or patients transitioning from adolescence to adulthood.
  3. Integrate the current evidence of the risks and benefits of growth hormone therapy with patient specific characteristics to decide on initiation of growth hormone therapy.
VIEW PRESENTATION
5:15-6:00 pm

Pituitary Case Studies -

Susan L. Samson, MD, PhD, FRCPC, FACE

                                    Objectives:

  1. Review the anatomy and physiology of the pituitary gland.
  2. Discuss the causes of hyperprolactinemia and the indications for treatment.
  3. Formulate a differential diagnosis of sellar and suprasellar masses beyond pituitary adenomas based on clinical presentation
VIEW PRESENTATION
6:00pmAdjourn 
6:30-8:00 pm

Dinner - Communication in Health Care (MB) -

Daniel Hurley, MD, FACE

VIEW PRESENTATION

PROGRAM - SATURDAY, NOVEMBER 9, 2019

Endocrine Laboratory Testing and Reproductive Technologies (HB)

Schedule and Sessions
Time
Event
Supporting Files
6:45-7:30 a.m. 

Breakfast and Exhibits (HBF)

 
7:30-8:30 a.m.

Diagnostic Evaluation of Pheochromocytoma

Sina Jasim, MD

                                    Objectives:

  1. Review the diagnostic approach to the patient with possible pheochromocytoma.
  2. Demonstrate the various localization studies available to the endocrinologist.
  3. Discuss the role for genetic testing in the setting of paraganglioma or pheochromocytoma.
  4. Review follow-up strategies following resection of a pheochromocytoma.
VIEW PRESENTATION
8:30–9:30 a.m. 

Hyperaldosteronism -

Irina Bancos, MD

                                    Objectives: 

  1. Review the epidemiology and indications for testing for hyperaldosteronism
  2. Demonstrate expertise in screening and confirmatory testing for hyperaldosteronism
  3. Summarize the key steps in performing and interpreting adrenal venous sampling

VIEW PRESENTATION

9:30–9:45 a.m.  

Break and Exhibits (HBF)

 
9:45-10:45 a.m. 

PCOS: Diagnostic Pearls and Management Strategies

Rachel Pessah-Pollack, MD, FACE

                              Objectives:

  1. Discuss diagnostic criteria and how to individualize test selection.
  2. Select among treatment options based on patient goals.
  3. Review how to screen and treat for co-morbidities of PCOS.
VIEW PRESENTATION
10:45-11:45 a.m.

Cutting Edge Reproductive Endocrinology

Chandra C. Shenoy, MD

                                    Objectives:

  1. Review basic reproductive endocrinology testing for the evaluation of fertility problems.
  2. Discuss types of fertility treatment and their anticipated success rates.
  3. Identify the latest technological advancements for deferring reproduction.
VIEW PRESENTATION
12:00-1:30 p.m. 

Lunch Talk - Transgender Health for Endocrinologists:  A Case-Based Approach (MB) 

Vin Tangpricha, MD, PhD, FACE and Caroline Davidge-Pitts, MBBCh

                                    Objectives:

  1. Review definitions and terminology in transgender health.
  2. Discuss the reason and modalities for medical management of transgender people.
  3. Review cross hormone therapy and surgical techniques and discuss some challenges in management.
VIEW PRESENTATION
1:30-2:00 p.m. 

Bone Module (HB)

Moderator:  Robert A. Wermers, MD, FACE

Clinical Approach to Metabolic Bone Disease  - 

Robert A. Wermers, MD, FACE

Objectives:

  1. Describe a general clinical approach to metabolic bone diseases.
  2. Appreciate causes of high bone mass.
  3. Explain causes of low bone mass.
VIEW PRESENTATION
2:00 – 3:00 p.m.

Pharmacologic Approaches to Osteoporosis, Therapies and Cases -

Matthew Drake, MD, PhD – moderator

Kurt A. Kennel, MD – Tools for Screening and Monitoring Osteoporosis (OP) Therapy

Ann E. Kearns, MD – Antiresorptive Therapy in the Treatment of OP

Matthew T. Drake, MD – Anabolic Therapy in the Treatment of OP

                                    Objectives:

  1. Describe the current recommended approach and tools used to screen for and monitor OP
  2. Review the use of antiresorptive drugs in OP therapy; their risks, benefits and differences
  3. Discuss the role for anabolic therapy in OP management

VIEW PRESENTATION

VIEW PRESENTATION

VIEW PRESENTATION

3:30-4:00 p.m.   

Coffee Break & Exhibits (HBF)

 
4:00-4:45 p.m. 

Hypercalcemia and Hypocalcemia -

Robert A. Wermers, MD, FACE and Matthew Drake, MD

                                  Objectives:

  1. Review the causes, evaluation, and pitfalls in hypercalcemic disorders
  2. Discuss the causes, evaluation, and treatment of hypocalcemia, including hypoparathyroidism.
VIEW PRESENTATION
4:45-5:45 p.m.  

Renal Bone Disease and Kidney Transplant

Daniel L. Hurley, MD, FACE and Robert A. Wermers, MD, FACE

                                    Objectives:

  1. Evaluate the complexity of mineral and bone disorders (MBD) in chronic kidney disease (CKD) including bone turnover (T), volume (V), and mineralization (M).
  2. Recognize the value of bone biopsy/histomorphometry in the assessment of MBD-CKD
  3. Review the limitations of current therapies in the treatment of MBD-CKD.
  4. Discuss management considerations of MBD-CKD before and after renal transplantation.
VIEW PRESENTATION
5:45-6:00 p.m.   

Question and Answer Session

 
7:00-9:00 p.m. 

Pizza Roundtable Discussions (MB)

 

PROGRAM - SUNDAY, NOVEMBER 10, 2019

The Essentials of Achieving a Successful and Rewarding Practice (HB)

Schedule and Sessions
Time
Event
Supporting Files
7:00-7:30 a.m. 

Breakfast and Exhibits (HBF)

 
7:30-8:15 a.m.

The Year Update in Diabetes

Yogish C. Kudva, MBBS

                                    Objectives:

  1. Identify the most significant clinical and translational research advances that have been made in the last year in the fields of diabetes.
  2. Describe how the translational and clinical research data can be applied in the future to improve patient care in the clinic and hospital settings.
  3. Discuss the impact of the new discoveries on clinical practice.
VIEW PRESENTATION
8:15–9:00 a.m. 

Update in Thyroid -

Juan P. Brito Campana, MBBS

                                    Objectives:

  1. Identify the most significant clinical and translational research advances that have been made in the last year in the fields of thyroid.
  2. Describe how the translational and clinical research data can be applied in the future to improve patient care in the clinic and hospital settings.
  3. Discuss the impact of the new discoveries on clinical practice.

VIEW PRESENTATION

9:00–9:30 a.m.  

Break and Exhibits (HBF)

 
9:30-10:30 a.m. 

The Business of Medicine - 

W. Reid Litchfield, MD, FACE, ECNU; Jad Sfeir, MD; Sandra L. Weber, MD, FACP, FACE

VIEW PRESENTATION

VIEW PRESENTATION

VIEW PRESENTATION

10:30-11:30 a.m.

The Business of Medicine - Contracts, Third Party Payers, and Staffing

Robert W. Liles, Esq

VIEW PRESENTATION
11:30 a.m.

Endocrine University® Adjourns

 

Faculty

Click/Touch to Expand

 

 

Dev Abraham MD, MRCP (UK), ECNU, FACE

Professor of Medicine (Clinical)

Adjunct Professor of Surgery and Pathology

Assistant Dean of Academic Affairs, School of Medicine,

University of Utah,

Salt Lake City, UT

Beverly MK Biller, MD, FACP
Professor of Medicine

Harvard Medical School

Neuroendocrine Unit, Massachusetts General Hospital

Boston, MA

Bruce W. Bode, MD, FACE

Atlanta Diabetes Associates

Associate Professor of Medicine

Emory University School of Medicine

Atlanta, GA

Alice Chang, MD. MSc

Associate Professor

Division of Endocrinology, Metabolism and Nutrition

Mayo Clinic

Rochester, MN

Bart Clarke, MD, FACP, FACE

Professor of Medicine,

Mayo Clinic College of Medicine

Rochester, MN

Caroline Davidge-Pitts, MBBCH

Internist, Endocrinologist
Endocrinology, Diabetes, Metabolism and Nutrition

Mayo Clinic
 Rochester, MN

Diana Dean, MD, FACE

Associate Professor of Medicine

Mayo Clinic of Medicine

Rochester, MN

Matthew Drake, MD

Mayo Clinic College of Medicine

Rochester, MN

James Garrity, MD

Professor of Ophthalmology

Mayo Clinic of Medicine

Rochester, MN

W. Timothy Garvey, MD. FACE

Professor and Chair, Department of Nutrition Sciences

University of Alabama at Birmingham

Director, UAB Diabetes Research Center
Birmingham, AL

 

Hossein Gharib, MD, MACP, MACE

Dean, Endocrine University®

Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

George Grunberger, MD, FACP, FACE

Chairman, Grunberger Diabetes Institute

Clinical Professor, Internal Medicine and Molecular Medicine & Genetics

Wayne State University School of Medicine

Professor, Internal Medicine

Oakland University Beaumont School of Medicine

Visiting Professor, First Faculty of Medicine, Charles University, Prague

Detroit, MI

R. Mack Harrell, MD, FACP, FACE, ECNU
President – American College of Endocrinology
Co-Director Memorial Center for Integrative Endocrine Surgery

Hollywood, Pembroke Pines, Weston and Boca Raton, Florida

Irl B. Hirsch, MD

Professor of Medicine

University of Washington School of Medicine

Seattle, WA

Mimi Hu, MD

Associate Professor

Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas M. D. Anderson Cancer Center
 Houston, TX

Mimi Hu, MD

Associate Professor

Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas M. D. Anderson Cancer Center
 Houston, TX

Daniel L. Hurley, MD, FACE

President Elect, American Association of Clinical Endocrinologists –

Assistant Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Jani Jensen, MD

Reproductive Medicine and Infertility Associates
 Edina, MN

Ann E Kearns, MD, PhD

Associate Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Kurt A. Kennel, MD

Assistant Professor of Medicine

Program Director, Endocrinology Fellowship Program

Division of Endocrinology, Metabolism and Nutrition

Mayo Clinic College of Medicine
Rochester, MN

Robert A. Levine, MD, FACE, ECNU

Thyroid Center of New Hampshire
Saint Joseph Hospital Endocrinology

Adjunct Assistant Professor of Medicine

Geisel School of Medicine - Dartmouth College

Nashua, NH

Robert Liles

Liles Parker

Washington DC

Francisco Lopez-Jiminez, MD
Professor of Medicine

Mayo College of Medicine

Chair, Division of Preventive Cardiology

Department of Cardiovascular Medicine

Rochester, Minnesota

Mark A. Lupo, MD, FACE, ECNU

Assistant Clinical Professor

Florida State University College of Medicine

Thyroid & Endocrine Center of Florida

Sarasota, FL

Debra Margulies, MD, FACE, ECNU
Summit Medical Group

New Jersey Chapter of AACE, Board of Directors

Morristown, NJ

 

Mira Milas, MD

Professor of Endocrine surgery

University of AZ

Phoenix, AZ

 

Richard Pratley, MD

Transitional Research Institute for Metabolism and Diabetes

Orlando, FL

Michael Rivera, MD
Assistant Professor

Department of Pathology

Mayo Clinic

Rochester, MN

Susan Samson, MD

Associate Professor of Medicine

Baylor College of Medicine

Houston, TX

Meera Shah

Mayo Clinic College of Medicine

Rochester, MN

Vinaya Simha

Mayo Clinic College of Medicine

Rochester, MN

Ravinder Singh, MD
Professor and Clinical Mass Spectrometry Laboratory Director

Department of Laboratory Medicine and Pathology

Mayo Clinic

Rochester, MN

J. Woody Sistrunk, MD, FACE, ECNU

Jackson Thyroid and Endocrine Clinic, PLLC

Jackson, MS

Marius N. Stan, MD, MSc

Assistant Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Dace Trence, MD, FACE
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition

Director, Endocrine Fellowship Program

Director, Diabetes Care Center

University of Washington

Seattle, WA

Vin Tangpricha, MD, PhD, FACE
Professor of Medicine

Department of Endocrinology, Metabolism and Lipids

Emory University School of Medicine

Atlanta, GA

Robert A. Wermers, MD, FACE

Associate Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

William F. Young, Jr., MD, MSc, FACP, FACE

Professor of Medicine

Mayo Medical School

Mayo Clinic

Rochester, MN

 

 

 

Disclosures
Faculty Disclosures
Bart Clarke
  1. Allergan
  2. Bristol Myers Squibb
  3. Takeda
  1. Consulting Fees
  2. Consulting Fees
  3. Research Grant
Bruce Bode
  1. Abbott
  2. Aseko
  3. AstraZeneca
  4. Becton Dickinson
  5. Boehringer Ingelheim
  6. DexCom
  7. Diasome
  8. Eli Lilly
  9. Insulet
  10. MannKind
  11. Medtronic
  12. Novo Nordisk
  13. Sanofi
  14. Senseonics 
  1. Research Grant
  2. Research Grant
  3. Honorarium, Research Grant
  4. Research Grant
  5. Honorarium, Research Grant
  6. Research Grant
  7. Research Grant
  8. Research Grant
  9. Research Grant
  10. Honorarium, Research Grant
  11. Honorarium, Research Grant
  12. Honorarium, Consulting Fees, Research Grant
  13. Honorarium, Research Grant
  14. Honorarium, Research Grant
Dace Trence
  1. Medtronic
  2. Sanofi-Aventis
  1. Stockholder
  2. Stockholder
George Grunberger       1. Medtronic       1. Contract Research
Irl Hirsch
  1. Abbott Diabetes Care
  2. Becton Dickinson
  3. BigFoot
  4. Medtronic Diabetes
  5. Roche
  1. Consulting Fees
  2. Consulting Fees
  3. Consulting Fees
  4. Grant/Research Support
  5. Consulting Fees
Jani Jensen       1. Ferring       1. Consulting Fees
Mimi Hu
  1. Blueprint Medicines
  2. Loxo Oncology
  1. Consulting Fees, Contracted Research
  2. Consulting Fees, Contracted Research
Richard Pratley
  1. AstraZeneca
  2. Eli Lilly
  3. GlaxoSmithKline
  4. Janssen
  5. Lexicon
  6. Ligand Pharmaceuticals, Inc.
  7. Merck
  8. Mundipharma
  9. Novo Nordisk
  10. Sanofi 
  1. Consulting Fees
  2. Consulting Fees, Grant/ Research Support
  3. Consulting Fees
  4. Consulting Fees, Grant/ Research Support
  5. Grant/Research Support
  6. Consulting Fees, Grant/ Research Support
  7. Consulting Fees, Grant/ Research Support
  8. Consulting Fees
  9. Honorarium, Consulting Fees, Research Grant
  10. Consulting Fees, Grant/ Research Support
Robert Wermers      1. Alexion Pharmaceuticals, Inc1.  Research Grant
Rodica Pop-Busui
  1. AstraZeneca
  2. Novo Nordisk
  1. Research Grant
  2. Consulting Fees
W. Timothy Garvey
  1. Sanofi
  2. Novo Nordisk
  3. Merck
  4. Pfizer
  5. Gilead
  6. Amgen
  7. BOYDSense
  1. Contracted Research
  2. Contracted Research, Consultant
  3. Contracted Research
  4. Contracted Research
  5. Consultant
  6. Consultant
  7. Consultant
Emily Smith
  1. CIVCO Medical Solutions
  2. Veracyte
  1. Salary
  2. Consulting Fees
Kevin Rooker       1.CIVCO Medical Solutions       1. Salary

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

 

Available Credit

  • 22.00 AMA
  • 22.00 Attendance

Accreditation Period

Course opens: 
11/05/2019
Course expires: 
12/31/2019
Please login or register to take this course.